Litcius/Paper detail

Donafenib: First Approval

Susan J. Keam, Sean T. Duggan

2021Drugs109 citationsDOI

Topics & Concepts

SorafenibMedicineHepatocellular carcinomaInternal medicineKinaseVandetanibLenvatinibVascular endothelial growth factorCancer researchOncologyVEGF receptorsPharmacologyCell biologyBiologyCancer Genomics and DiagnosticsLung Cancer Treatments and MutationsChemical Reactions and Isotopes
Donafenib: First Approval | Litcius